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1. Introduction 
Human plasminogen, a single-chain polypeptide 
containing about 8 10 amino acid residues, is 
converted on activation to plasmin, which possesses 
a heavy and a light chain containing about 5 10 and 
230 residues, respectively. Recent amino acid sequence 
studies [l-6] have demonstrated the existence of a 
high degree of internal homology within the heavy 
chain of plasminogen. In fact Magnusson and 
coworkers [ 1,2] have shown that about 80% of the 
heavy chain can be accounted for by five mutually 
homologous regions (‘kringles’) that are characterized 
by six invariant half-cystine residues and are also 
homologous with two analogous regions in pro- 
thrombin. 
The heavy chain sequence proposed by Magnusson 
and co-workers [ 1,2] * is based on overlapping sets of 
tryptic and chymotryptic peptides. In the present 
paper we present the results of our studies with the 
cyanogen bromide peptides of plasminogen, which, 
for the most part, confirm the assignments of 
Magnusson, but which also suggest hat the process 
of gene duplication in plasminogen occurred with less 
regularity than previously thought [ 1,2] . In addition 
we demonstrate the utility of a selective solid-phase 
peptide coupling technique for aligning cyanogen 
bromide peptides. 
* A revised version of the sequence presented in [ 1 ] is given 
in [2]. 
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2. Materials and methods 
Human plasminogen (lysine form [7]) was prepared 
from Cohn fraction III or IIIZ,a by the method of 
McClintock et al. [8]. 
Plasminogen was cleaved with cyanogen bromide 
as described earlier [3] and then chromatographed on 
Sephadex G-50 in 10% acetic acid to separate non- 
cystine peptides from the cystine core. The core was 
then reduced and carboxymethylated and further 
fractionated by gel filtration in 2.5% acetic acid and 
chromatography on DEAE cellulose and DEAE 
BioGel using N&HCOa gradient elution. In some 
cases, peptides were further cleaved with trypsin 
after maleylation. 
Overlapping methionine peptides were obtained by 
digestion of reduced, carboxymethylated plasminogen 
with trypsin, followed by separation of the peptides 
on Sephadex G-25, DEAE BioGel and Dowex-50 
columns. 
Sequencing was accomplished by solid-phase 
Edman degradation [9,10] using a Sequemat Model 12 
sequencer. Cyanogen bromide peptides were coupled 
to resins by the homoserine lactone method [ 1 l] , 
and lysine peptides by the diisothiocyanate method 
[ 121. In order to sequence the C-terminal portion of 
cyanogen bromide peptides, the peptide was digested 
with trypsin and the C-terminal fragment was selec- 
tively removed from the mixture by coupling the 
homoserine moieb’to a sequencing resin [ 11 ,131. 
Large peptides were attached to aminopropyl glass 
[ 141. Phenylthiohydantoins were,identified by 
thin-layer chromatography and HI hydrolysis to 
amino acids. 
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3. Results and discussion 
Cyanogen bromide cleavage of Lys-plasminogen 
gave nine peptides, of which eight were characterized 
in this work (tables 1 and 2). The ninth, CB-VIII, an 
approximately 200-residue peptide which comprises 
most of the light chain, precipitated in 2.5% acetic 
acid and did not elute from the Sephadex G-50 
column. 
The strategy used for alignment of the peptides 
involved sequencing of the N- and C-terminal portions 
of the peptides (or in some cases, the entire peptide), 
and then overlapping with the methionine-containing 
tryptic peptides. C-terminal sequencing was greatly 
facilitated by solid-phase methods, by which the 
C-terminal fragments of large cyanogen bromide 
peptides could be attached selectively to sequencing 
resins at homoserine after tryptic digestion [ 131. This 
Table 1 
Comparison of amino acid compositions of cyanogen 
bromide peptides CB-II and CB-VI from plasminogen. 
Nearest integral values are given for convenience 
CB-II CB-VI 
CBIIa Dbb ’ CBvIaDab c 
CMCys 8 8 6 7 7 5 
ASP 12 12 8 12 11 8 
Thr 7 8 6 6 6 3 
Ser 8 8 6 7 6 4 
GlU 15 14 10 8 8 5 
F-IO 12 11 9 14 12 9 
Gly 5 4 3 3 3 2 
Ala 21 1 5 4 3 
Val 0 0 0 8 9 6 
Ile 4 3 2 0 0 0 
LeU 4 3 2 5 5 3 
Tyr 7 6 4 4 4 2 
Phe 22 1 2 2 1 
Trp n.d. 3 2 n.d. 3 2 
His 3 2 2 0 0 0 
LYS 5 5 4 4 4 5 
Arg 5 5 4 3 3 2 
Hse (1) (1) (1) -- (1) 0 0 
Total 100 96 73 89 88 61 
a This work. 
b The corresponding peptides reported by Wiman and Wallen 
(51. 
c From sequence data of Magnusson et al. [2]. 
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work represents the first example of the use of this 
strategy in aligning the peptides of an entire protein. 
Tables 2 and 3 list sequence data for cyanogen 
bromide peptides and tryptic peptides containing 
methionine, respectively. The alignment of these 
peptides is shown in fig. 1. 
In general our results confirm those of Magnusson 
et al. [ 1,2] , who found the heavy chain to be 
comprised primarily of five homologous segments 
(referred to as ‘kringles’ by Magnusson) of about 
80 residues each. These regions are also homologous 
with two similar regions in prothrombin (fig.2), and 
are characterized by six invariant half-cystine residues 
which are believed to form three disulfide loops in 
each kringle [2]. Some homology (analogy) is also 
seen in the non-kringle regions (lig.2). 
The main discrepancy between our data and that 
of Magnusson et al. [ 1,2] lies in peptide CB-VI, where 
we find a 22-residue segment with the sequence 
Val-Val-Ser-Gly-Pro-Glu-Trp-Val-Val-Ieu- 
Lys-Pro-Asp-Glu-Gly-Thr-Leu-Leu-Glu- 
Asp-Asp-Lys, whereas Magnusson fmds Lys-Lys, 
Lys-Lys (table 2). Thus according to our results, 
kringle D (fig.2) is approximately 20 residues longer 
than the others. Furthermore, this 20-residue 
segment (D’ in fig.2) appears to have arisen by dupli- 
cation of part of the sequence immediately following 
it. Wiman and Wallen [5] have also isolated CB-VI 
and report an amino acid composition and mol. wt. 
(9000) consistent with our findings (table 1). 
A second difference is seen in peptide CB-II which 
both we and Wiman and Wallen find to have a mol. wt. 
of at least 11 000 and an amino acid composition of 
around 100 residues, whereas Magnusson et al. [ 1,2] 
find only 72 residues. Although our sequence 
analysis of this peptide is not complete, we find some 
peptides derived from CB-VI that do not fit 
Magnusson’s equence, indicating that it, and therefore 
kringle A, may be larger than indicated in fig.2. 
Despite a few discrepancies that remain to be 
resolved, our results provide an independent confirma- 
tion of Magnusson’s sequence, which shows that the 
heavy chain of plasminogen is composed of five 
homologous regions resulting from multiple gene 
duplication. At this time we do not know whether 
any of the differences are due to errors in sequencing 
or to isolation of different microheterogeneous 
forms [7,16] of plasminogen. 
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Table 2 
Sequence data for cyanogen bromide peptides. Peptides are numbered in order, starting with the N-terminal peptide. Unless 
otherwise noted, the sequences were determined in our laboratory. Underlined amino acids indicate residues confirmed by 
Wiman and Wallen [4-61. Amino acids given in capitals are residues found by Magnusson et al. [ 1,2] which differ from 
our assignments; otherwise the two sets of data are in agreement. 
Peptide Sequence 
CB-I NH,-Lys-Val-Tyr-Leu-Ser-Glu-Cys-Lys-Thr-Gly-XXX-Gly-XXX-~n-Tyr-Arg-Gly-Thr-Hse -_- ----- -- 
ASP LYS 
CB-II Ser-Lys-Thr-Lys-Asn-Gly-Ile-(ca. 80 residues)-Arg-Tyr-Asp-Tyr-Cys-Asp-Ile-Leu-Glu-Cys-Glu- ---_-- 
GLX 
Glu-Glu-Cys-Hse 
CB-III His-Cys-Ser-Gly-Glu-Asn-Tyr-Asp-Gly-Lys-Be-Ser-Lys-~r-Hse 
GLX ASX 
CB-IV Ser-Gly-Leu-Glu-Asn-Gln-Ala-Lys-Ser-(ca. 185 residues)-XXX-Gln-Ser-Trp-XXX-XXX-Hse 
CYS TRP - CYS SER SER 
CB-V Thr-Pro-His-Arg-His-Gln-Lys-Thr-Pro-Glu-Asn-Tyr-Pro-Asn-Ala-Gly-Leu-Thr-Hse 
GLX GLX ASX 
CB-VI Asn-Tyr-Cys-Arg-Asn-Pro-Asp-Ala-Asp-Gly-Gly-Pro-Trp-Cys-Phe-Val-Thr-Asp-XXX-XXX-XXX-Arg- 
ASX ASX ASX THR 
Arg Val 
Trp-Glu-Tyr-Cys-Asn-Leu-Lys-Val-Val-Ser-Gly-Pro-Glu-Trp-V~-Val-Leu-Lys-~o-Asp-Glu-Gly- 
LYS-LYS,LYS-LYS - - - - - - - - - - - - 
Thr-Leu-Leu-Glu-Asp-Asp-Lys-Cys-Ser-Gly-Thr-Glu-Ala-Ser-Val-Val-Ala-Pro-Pro-Pro-Val-Val-Leu- 
GLX (PRO,PRO,VAL,LEU, 
Leu-Pro-Asn-Val-Glu-Po-Pro-Ser-Glu-Glu-Ap--Cys-Hse 
LEU,PRO,ASX,VAL,GLX,PRO,PRO,SER,GLX,GLX,ASX,CYS,MET) 
CB-VIIa Phe-Gly-Asn-Gly-Lys-(113 residues)-Arg-Phe-Gly-Hse -- ---- 
CB-VIIIb His-Phe-Cys-Gly-Gly-Thr-Leu-Ile-Ser-Pro-Gly-Trp-Val-Leu-Se;-Ala-~a-(ca. 185 residues)-Hse - 
CB-IX Arg-Asn-Asn-COOH --- 
a The complete sequence of this peptide has been reported by Wiman and Wallen [4]. 
b The N-terminal sequence of this peptide was determined by Robbins et al. [ 151. 
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Fig.1. Alignment of cyanogen bromide peptides in plasminogen. The heavy-chain kringle regions (A-E) are indicated by open 
bars, and the inter-kringle regions by cross-hatching. 
Table 3 
Sequence data for tryptic peptides containing methionine 
Tl 
T2 
Gly-Th-Met-Ser-Lys - 
Tyr-Asp-Tyr-Cys-Asp-Ile-Leu-Glu-Glu-~s-Glu-Glu-Glu-Cys-Met-His-Cys-Ser-Gly-Glu-Asn-Tyr- - 
Asp-Gly-Lys 
T3 Thr-Met-Ser-Gly-Leu-Glu-Asn-Gln-Ala-Lys - 
T4 Cys-Gln-Scr-Trp-Ser-Ser-Met-Th-Pro-Hi-Arg 
TS Thr-Pro-Glu-Asn-Tyr-Pro-Asn-Ala-Gly-Leu-~r-Met-Asn-Tyr-Cys-Arg - 
T6a Cys-Ser-Gly-Thr-Glu-Ala-Ser-Val-Val-ALa-Pro-Pro-Pro-Val-Val-Leu-Leu-Pro-Asn-Val-Glu-Pro-Pro- 
(Ser,Glx,Glx,Asx,Cys)-Met-Phe-Gly-Asn-Gly-Lys 
7 
T7b Phe-Gly-Met-His-Phe-Cys-Gly-Gly-Thr-Leu-Ile-Ser-Pro-(Glx,Trp,Val,Leu,Ser,Ala,His,Cys,Leu)-Lys - 
T8 (Cys, Asx, Thr, Glx, Pro, Gly, Ala, Val, His, )-Met-Arg 
a Not sequenced entirely. The portion in parentheses was deduced from the compositions and known sequences of CB-VI and 
CB-VII. 
b Not sequenced entirely. Sequence in parentheses corresponds to that reported by Robbins et al. [ 151. 
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